These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38943996)

  • 21. DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues.
    Zhang S; He S; Zhu X; Wang Y; Xie Q; Song X; Xu C; Wang W; Xing L; Xia C; Wang Q; Li W; Zhang X; Yu J; Ma S; Shi J; Gu H
    Nat Commun; 2023 Sep; 14(1):5686. PubMed ID: 37709764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).
    Vibert J; Pierron G; Benoist C; Gruel N; Guillemot D; Vincent-Salomon A; Le Tourneau C; Livartowski A; Mariani O; Baulande S; Bidard FC; Delattre O; Waterfall JJ; Watson S
    J Mol Diagn; 2021 Oct; 23(10):1380-1392. PubMed ID: 34325056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
    Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
    Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimalist approaches to cancer tissue-of-origin classification by DNA methylation.
    Xia D; Leon AJ; Cabanero M; Pugh TJ; Tsao MS; Rath P; Siu LL; Yu C; Bedard PL; Shepherd FA; Zadeh G; Chetty R; Aldape K
    Mod Pathol; 2020 Oct; 33(10):1874-1888. PubMed ID: 32415265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
    Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
    Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of DNA methylation-based tumor types from histopathology in central nervous system tumors with deep learning.
    Hoang DT; Shulman ED; Turakulov R; Abdullaev Z; Singh O; Campagnolo EM; Lalchungnunga H; Stone EA; Nasrallah MP; Ruppin E; Aldape K
    Nat Med; 2024 Jul; 30(7):1952-1961. PubMed ID: 38760587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
    Moran S; Martínez-Cardús A; Sayols S; Musulén E; Balañá C; Estival-Gonzalez A; Moutinho C; Heyn H; Diaz-Lagares A; de Moura MC; Stella GM; Comoglio PM; Ruiz-Miró M; Matias-Guiu X; Pazo-Cid R; Antón A; Lopez-Lopez R; Soler G; Longo F; Guerra I; Fernandez S; Assenov Y; Plass C; Morales R; Carles J; Bowtell D; Mileshkin L; Sia D; Tothill R; Tabernero J; Llovet JM; Esteller M
    Lancet Oncol; 2016 Oct; 17(10):1386-1395. PubMed ID: 27575023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pan-Cancer DNA Methylation Analysis and Tumor Origin Identification of Carcinoma of Unknown Primary Site Based on Multi-Omics.
    Liu P
    Front Genet; 2021; 12():798748. PubMed ID: 35069697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
    Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
    Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accurate prediction of pan-cancer types using machine learning with minimal number of DNA methylation sites.
    Ning W; Wu T; Wu C; Wang S; Tao Z; Wang G; Zhao X; Diao K; Wang J; Chen J; Chen F; Liu XS
    J Mol Cell Biol; 2023 Aug; 15(4):. PubMed ID: 37037781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imputing missing RNA-sequencing data from DNA methylation by using a transfer learning-based neural network.
    Zhou X; Chai H; Zhao H; Luo CH; Yang Y
    Gigascience; 2020 Jul; 9(7):. PubMed ID: 32649756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AI-based pathology predicts origins for cancers of unknown primary.
    Lu MY; Chen TY; Williamson DFK; Zhao M; Shady M; Lipkova J; Mahmood F
    Nature; 2021 Jun; 594(7861):106-110. PubMed ID: 33953404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma.
    Ye MH; Huang XY; Li CJ; Wu QJ; Liu F
    Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational Detection of Breast Cancer Invasiveness with DNA Methylation Biomarkers.
    Wang C; Zhao N; Yuan L; Liu X
    Cells; 2020 Jan; 9(2):. PubMed ID: 32019269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinoma.
    Xi Y; Lin Y; Guo W; Wang X; Zhao H; Miao C; Liu W; Liu Y; Liu T; Luo Y; Fan W; Lin A; Chen Y; Sun Y; Ma Y; Niu X; Zhong C; Tan W; Zhou M; Su J; Wu C; Lin D
    Signal Transduct Target Ther; 2022 Feb; 7(1):53. PubMed ID: 35210398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PathMethy: an interpretable AI framework for cancer origin tracing based on DNA methylation.
    Xie J; Song Y; Zheng H; Luo S; Chen Y; Zhang C; Yu R; Tong M
    Brief Bioinform; 2024 Sep; 25(6):. PubMed ID: 39391931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
    Li X; Zhang W; Song J; Zhang X; Ran L; He Y
    Clin Epigenetics; 2019 Jul; 11(1):99. PubMed ID: 31288850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer.
    Peng Y; Shui L; Xie J; Liu S
    J Cell Mol Med; 2020 Aug; 24(16):9378-9387. PubMed ID: 32649035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.